NSRX Stock Analysis: Buy, Sell, or Hold?
NSRX - Nasus Pharma Ltd.
$3.01
-0.06 (-1.95%)
▼
5d:
+2.73%
30d:
-1.95%
90d:
+33.78%
BUY
HIGH Confidence
Analysis Updated: Jul 17, 2026 12:00 AM ET
Earnings: Jun 24, 2026
0d
Get Alerted When NSRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: NSRX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: NSRX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: NSRX is currently trading at $3.01, which is considered slightly low relative to its 30-day fair value range of $3.00 to $3.36.
Technical Outlook: Technically, NSRX is in a downtrend. The price is currently testing key support at $2.93. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $19.67 (+553.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, NSRX is in a downtrend. The price is currently testing key support at $2.93. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $19.67 (+553.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$3.00 -
$3.36
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 553.4% below Wall St target ($19.67)
Trading Range Analysis
30-Day Trading Range
$3.00 -
$3.36
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$2.93
Resistance Level
$3.64
Current Trend
Downtrend
Technical data as of
Jul 17, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.28
Wall Street Target
$19.67
(+553.4%)
Share & Embed Analysis
Last updated: July 19, 2026 10:48 AM ET
Data refreshes hourly during market hours. Next update: 11:48 AM
Data refreshes hourly during market hours. Next update: 11:48 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NSRX showing a specific setup today?
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
31 analysts |
$1270 | 59 HOLD |
|
GILD
Gilead Sciences Inc |
BUY
30 analysts |
$158 | 66 BUY |
|
ABBV
AbbVie Inc |
BUY
28 analysts |
$267 | 64 BUY |
|
AMGN
Amgen Inc |
HOLD
32 analysts |
$357 | 62 BUY |
|
BIIB
Biogen Inc |
HOLD
37 analysts |
$226 | 55 HOLD |